1 / 42

MYCOBACTERIAL  DISEASES

MYCOBACTERIAL  DISEASES. Data are as reported to WHO. Estimates of TB and MDR -TB burden are produced by WHO in consultation with countries. * Ranges represent uncertainty intervals. Mycobacterium tuberculosis. Obligate aerobe acid-fast rods. TUBERCULOSIS OVERVIEW , CAUSE, AND PATHOGENESIS.

dolf
Download Presentation

MYCOBACTERIAL  DISEASES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MYCOBACTERIAL  DISEASES

  2. Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries. * Ranges represent uncertainty intervals

  3. Mycobacterium tuberculosis Obligate aerobe acid-fast rods

  4. TUBERCULOSIS OVERVIEW, CAUSE, AND PATHOGENESIS • Tuberculosis, MTB, or TB (short for tubercle bacillus) • common, and in many cases lethal infectious disease • caused by various strains of mycobacteria • usually Mycobacterium tuberculosis • Mycobacterium tuberculosis, was identified and described on 24 March 1882 by Robert Koch • Tuberculosis may infect any part of the body • most commonly occurs in the lungs • pulmonary tuberculosis

  5. Tuberculosis holds a special place in medical history • Can humble master clinicians • challenge public health authorities • treatable and preventable • WHO (TB) data • 2 million deaths occur worldwide, each year • Over 8 million cases, each year • In 2012, nearly 9 million people around the world became sick • around 1.3 million TB-related deaths worldwide • ≤ 33% of world’s population have silent latent infection 

  6. The Difference between Latent TB Infection (LTBI) and TB Disease

  7. Tuberculosis in the United States is now largely a disease of the disadvantaged • In 2006, there were 13,767 reported cases of TB in the United States • cases were reported in every state • drug-resistant cases • co-infection with M. tuberculosis and HIV • estimated 10 to 15 million persons remain latently infected • A total of 9,945 TB cases were reported in the United States in 2012 • Both the number of TB cases reported and the case rate decreased • this represents a 5.4% and 6.1% decline, respectively, compared to 2011

  8. Mycobacteriumtuberculosis • Mycobacterium tuberculosis • slightly curved or straight rod-shaped bacillus • requires special acid-fast stains to be visualized • It is closely related to M. bovis • primarily pathogen of cattle and related animals • M. tuberculosis is also related to M. leprae • leprosy

  9. Tuberculosis is spread from person to person • through the air by droplet nuclei • 1 to 5 m in diameter that have been expulsed into the air • Cough is the primary means by which tubercle bacilli are aerosolized • singing, sneezing, or speaking may contribute to a lesser extent • Droplet nuclei • small enough to remain suspended in the air for long time • The probability of transmission depends on numerous factors • source case • exposed contact • air space shared

  10. Usual pathogenesis of tuberculosis. About 5% of infected persons develop clinical disease within the first year of infection; another 5% develop reactivation later during their lives.

  11. TB pathogenesis begins when a droplet containing viable tubercle bacilli isinhaled • Bacilli then spread through the pulmonary lymphatics • reach lymph nodes • may become enlarged • Efferent lymphatics then carry bacilli into the systemic circulation • lungs, brain, kidneys, and bones • Tubercle bacilli replicate relatively slowly • dividing time within 18 to 24 hours • 20 minutes for most common pathogens • Thus, the process of local, lymphatic, and eventual systemic spread described above typically requires several weeks

  12. PULMONARY TUBERCULOSIS • Worldwide, tuberculosis remains the most common cause of death • Pulmonary tuberculosis is the most common manifestation and the form of the disease usually responsible for its transmission • The usual patient with pulmonary tuberculosis presents with a history of several weeks of a progressive illness • The most important pulmonary symptom is cough • Constitutional complaints coexist and may predominate • fever, chills, night sweats, weight loss, appetite loss, and easy fatigability

  13. HIV and TB • HIV has greatly increasing the risk of TB • Diagnosis of TB in patients with HIV can be difficult • Suspicion of TB is an indication for HIV antibody testing

  14. Laboratory diagnosis • 1- Mantoux skin test (Tuberculin) • 2- Chest X-ray • 3- Isolation of Mycobacterium species • Löwenstein–Jensen medium (L.J. medium) • microscopic positive results for acid-fast bacilli • 4- Identification of microbial genetic material • molecular methods such as PCR

  15. Positive skin test - tuberculosis • indicates exposure to organism • does not indicate active disease

  16. The Mantoux skin test consists of an intradermal injection of one-tenth of a milliliter (ml) of PPD tuberculin.

  17. The size of induration is measured 48–72 hours later. Erythema (redness) should not be measured.

  18. Mantoux test injection site in a subject without chronic conditions or in a high-risk group clinically diagnosed as negative at 50 hours

  19. Skin testing for tuberculosis, using the Mantoux test.

  20. Chest X-ray

  21. Microscopic Examination of Mycobacterium • The Mycobacteria are aerobic acid fast, non-motile, non-spore forming rods • M. tuberculosis is a non capsulated straight or slightly curved rod, measuring 1-4µm x 0.2-0.6 µm • The most common pathogens that cause disease to man are • M. tuberculosis, M. bovis, M. africanum, and M.microti

  22. Laboratory diagnosis M. tuberculosis • acid fast bacteria • sputum TB in Sputum

  23. M. tuberculosis is best demonstrated by using the Ziehl -Neelsen technique or a fluorescence technique. When stained by ZN, they appear as thin pink rods arranged singly or in groups. Once stained, they resist decolorization with 2% H2SO4 and alcohol or 3% HCl in 95% ethyl alcohol (Acid-fast, Alcohol fast).

  24. Cultural Characteristics and colony morphology • M. tuberculosis is strict aerobic • grows very slowly (2-4 weeks) • egg enriched medium • Lowenstein-Jensen medium • giving dry creamy colored colonies • Other selective media as Middlebrook 7H10, 7H11 agar and 7H9 broth • used for primary isolation • antibiotic susceptibility testing

  25. M. tuberculosis is a non chromogen • does not grow on media contain p-nitrobenzoic acid • these characteristics help to differentiate them from M. avium, M. intracellulare, and M. kansasii • The optimum temperature for growth is at 37C • The culture must be incubated up to 12 weeks • M. tuberculosisproduces rough, and tough colonies on glycerol and pyruvate egg media • They are niacin producers and grow under aerobic conditions at 37 C

  26. TB Culture Cultivation and culture characteristics of Tubercle bacilli on Lowenstein Jensen medium (raised dry cream colored colonies)

  27. Tuberculosis • polymerase chain amplification • rapid diagnosis

  28. Antibotic treatment - tuberculosis • extensive time periods (e.g. 9 months) • organism grows slowly, or dormant • two or more antibiotics • e.g. rifampin and isoniazid • resistance minimized

  29. Tuberculosis and Drug resistance • Multiple drug resistant (MDR) • Resistant to first line drugs • Extremely drug resistant (XDR) • Resistant to some of the second line drugs • Nearly un-treatable

  30. Transmission - tuberculosis • M. tuberculosis is carried in airborne particles, called droplet nuclei, of 1– 5 microns in diameter • Depending on the environment, these tiny particles can remain suspended in the air for several hours • M. tuberculosis is transmitted through the air, not by surface contact • Transmission occurs when a person inhales droplet nuclei containing M. tuberculosis • traverse the mouth or nasal passages, upper respiratory tract, and bronchi • reach the alveoli of the lungs

  31. Aerosol from Sneeze

  32. Vaccination • BCG vaccine • an attenuated strain of M. bovis • not effective • in US, • incidence is low • vaccination not practiced • immunization interferes with diagnosis

  33. An apparatus (4-5 cm length, with nine short needles) used for BCG vaccination in Japan. Shown with ampoules of BCG and saline.

  34. M. avium - M. intracellulare complex (M. avium) • non-AIDS • infection almost never • AIDS • major bacterial opportunist • multiple drug-resistance

  35. M. bovis • spread from cattle • infected cattle are culled • positive skin test • rarely seen in US

  36. M. leprae • leprosy • major disease of third world • rare in US

  37. A 24-year-old man from Norway, infected with leprosy, 1886.

  38. Deformities from leprosy in India

More Related